SWEDISH ORPHAN BIOVITRUM LTD

Active Cambridge

Manufacture of pharmaceutical preparations

60 employees website.com
Manufacture of pharmaceutical preparations
S

SWEDISH ORPHAN BIOVITRUM LTD

Manufacture of pharmaceutical preparations

Founded 8 Feb 2002 Active Cambridge, England 60 employees website.com
Manufacture of pharmaceutical preparations

Previous Company Names

SWEDISH ORPHAN INTERNATIONAL LTD 30 Aug 2002 — 11 Jun 2010
TRUNKSPACE LIMITED 8 Feb 2002 — 30 Aug 2002
Accounts Submitted 16 Sept 2025 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 23 Feb 2026 Next due 22 Feb 2027 9 months remaining
Net assets £24M £4M 2024 year on year
Total assets £50M £9M 2024 year on year
Total Liabilities £26M £5M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Suite 2, Building 3, Riverside Suite Granta Park Great Abington Cambridge CB21 6AD England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for SWEDISH ORPHAN BIOVITRUM LTD (04369760), an active company based in Cambridge, England. Incorporated 8 Feb 2002. Manufacture of pharmaceutical preparations. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 4 months remaining

Balance Sheet & P&L (2014–2024)

Cash in Bank

N/A

Net Assets

£23.60M

Increased by £4.32M (+22%)

Total Liabilities

£25.92M

Increased by £4.81M (+23%)

Turnover

£78.41M

Increased by £18.35M (+31%)

Employees

60

Increased by 6 (+11%)

Debt Ratio

52%

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Swedish Orphan Biovitrum International Ab
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Swedish Orphan Biovitrum International Ab (publ)

Sweden

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Group Structure

Group Structure

SWEDISH ORPHAN BIOVITRUM LTD Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
23 Feb 2026Confirmation StatementConfirmation statement made on 8 Feb 2026 with no updates
16 Sept 2025AccountsAnnual accounts made up to 31 Dec 2024
7 Mar 2025Confirmation StatementConfirmation statement made on 8 Feb 2025 with no updates
29 Nov 2024OfficersTermination of Simon Edward Cox as director on 29 Nov 2024
29 Nov 2024OfficersAppointment of Mr Steve Wesley Andrew Knott as director on 29 Nov 2024
23 Feb 2026 Confirmation Statement

Confirmation statement made on 8 Feb 2026 with no updates

16 Sept 2025 Accounts

Annual accounts made up to 31 Dec 2024

7 Mar 2025 Confirmation Statement

Confirmation statement made on 8 Feb 2025 with no updates

29 Nov 2024 Officers

Termination of Simon Edward Cox as director on 29 Nov 2024

29 Nov 2024 Officers

Appointment of Mr Steve Wesley Andrew Knott as director on 29 Nov 2024

Recent Activity

Latest Activity

Confirmation statement made on 8 Feb 2026 with no updates

2 months ago on 23 Feb 2026

Annual accounts made up to 31 Dec 2024

8 months ago on 16 Sept 2025

Confirmation statement made on 8 Feb 2025 with no updates

1 years ago on 7 Mar 2025

Termination of Simon Edward Cox as director on 29 Nov 2024

1 years ago on 29 Nov 2024

Appointment of Mr Steve Wesley Andrew Knott as director on 29 Nov 2024

1 years ago on 29 Nov 2024